Form 4: Movano Director Acquires Options, Preferred Stock

Movano Inc. director Emily Fairbairn reported acquiring stock options and preferred stock, linked to a merger with Corvex, Inc.

Summary

• Director Emily Fairbairn acquired 200,000 stock options to purchase Movano Inc. common stock at an exercise price of $15.09.
• The options vest in three equal annual installments on the anniversary of the grant date, starting March 18, 2027, and require shareholder approval to become exercisable.
• Fairbairn also acquired 9.2319 shares of Series B Preferred Stock on March 19, 2026, which will automatically convert into 92,319 shares of common stock on March 31, 2026, at a 1 to 1000 ratio.
• Additionally, 2,063.8228 shares of Series C Preferred Stock were acquired on March 19, 2026, convertible into 2,063,823 shares of common stock at a 1 to 1000 ratio upon shareholder approval, as per Nasdaq listing rules.
• Both preferred stock acquisitions were received in exchange for equity securities in Corvex, Inc. pursuant to the Amended and Restated Agreement and Plan of Merger, dated March 19, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a director's acquisition of equity, particularly through a merger, suggests confidence in the company's strategic direction and future value, despite the contingencies of shareholder approval.

Positives

• Director Emily Fairbairn's acquisition of stock options and preferred stock indicates a vested interest and confidence in the company's future performance.
• The preferred stock acquisitions are a result of the merger with Corvex, Inc., suggesting a strategic integration and expansion for Movano Inc.

Negatives

• The stock options require shareholder approval to become exercisable, introducing a potential contingency that could delay their full realization.
• The Series C Preferred Stock conversion also requires shareholder approval, which could delay the full realization of common stock ownership.

Risks

• Shareholder approval is required for the stock options to become exercisable, introducing uncertainty regarding the timing and certainty of their value realization.
• The conversion of Series C Preferred Stock into common stock is contingent on shareholder approval, which could impact the timing and certainty of the underlying common stock ownership.
• The value of the acquired options and preferred stock is subject to future stock price performance and the successful integration and performance of Corvex, Inc. post-merger.

Future Outlook

The filing indicates future events tied to shareholder approvals for option exercisability and preferred stock conversion, as well as the automatic conversion of Series B Preferred Stock by March 31, 2026. These events are contingent on internal processes and market conditions.

Industry Context

StockSavvy.ai notes that insider acquisitions, especially by directors, often signal confidence in the company's future prospects. The acquisition of preferred stock linked to a merger (Corvex, Inc.) suggests ongoing integration activities, which are common in the technology and healthcare sectors for expanding product portfolios or market reach.

Comparison to Industry Standards

• Director compensation packages often include stock options and restricted stock units to align management interests with shareholder value, a common practice across industries, including technology and biotech.
• The conversion ratios for preferred stock (1 to 1000) are specific to the terms of the merger agreement with Corvex, Inc. and would need to be compared against similar merger terms in the health tech or wearable device industry for a direct benchmark.
• The requirement for shareholder approval for option exercisability and preferred stock conversion is a standard corporate governance practice, particularly when new equity issuances or significant changes to existing equity are involved, ensuring compliance with Nasdaq listing rules and protecting existing shareholder interests.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential dilution from future common stock conversion of preferred shares and exercise of options, but also a signal of director confidence.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• Shareholder approval for the exercisability of the 200,000 stock options.
• Shareholder approval for the conversion of Series C Preferred Stock into common stock.
• Automatic conversion of Series B Preferred Stock into common stock on March 31, 2026.

Key Dates

Recommendation

The filing reports an insider's acquisition of equity, which is generally a positive signal of confidence. However, the transactions are tied to a merger and involve contingencies like shareholder approval for option exercisability and preferred stock conversion. Without further financial context or details on the merger's impact, a "hold" recommendation is prudent, acknowledging the positive insider action while awaiting more comprehensive information on the company's performance and strategic integration.

Keywords

Movano Inc., MOVE, SEC Form 4, Insider Transaction, Stock Options, Preferred Stock, Director Compensation, Merger, Corvex Inc., Equity Acquisition